Issue of Equity

Issue of Equity

Eco Animal Health Group Plc

ECO Animal Health Group plc
(“Eco” or the “Company”)(“Eco” or the “Company”)

15 December 2010

Application has been made to the London Stock Exchange for 90,000 Ordinary shares in the Company to be admitted to trading on AIM as a result of the exercise of options. It is anticipated that these shares will be admitted to trading on 21 December 2010.

The total number of voting Ordinary shares in issue following this exercise of options will be 52,195,172.

Enquiries
Eco Animal Health Group plcEco Animal Health Group plc
Peter Lawrence, Executive Chairman                 020 8336 6190 Peter Lawrence, Executive Chairman                 020 8336 6190

Spiro Financial	Â	Â	Â	Â	Â
Anthony Spiro						020 8336 6196
							Â
							Â
Cenkos Securities plc (Nominated adviser)
Stephen Keys						020 7397 8926
Elizabeth Bowman						020 7397 8928
							Â

ECO Animal Health Group plc is a leader in the development, registration and marketing of pharmaceutical products for animals. Our products for these global growth markets promote well-being. Our financial goals are achieved through the careful and responsible application of science to generate value for our shareholders.